NAS10026,906−5.38%S&P7,400−3.75%GOLD$4,127+1.33%BTC$76,159−5.28%VIX24.13+45.27%latest tape · as of 20:03 UTC
The Screen · Basic Materials · Other Precious Metals & Mining
Avino Silver & Gold Mines Ltd.
ASM · NYSE American · USD · Market cap $819M
Avino Silver & Gold Mines Ltd., together with its subsidiaries, engages in the acquisition, exploration, and advancement of mineral properties in Mexico.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.62, read 2026-11-05
Ethical passes the values gate
Price4.74 USD
Fair valueUnder review
Ethical score97.0/100
Our investment reviews on this name
2026-10-11Read Markdown5.91-19.8% to today ✓Distribution gives way to Markdown first Markdown read since September
2026-10-02Read Distribution5.91-19.8% to today ✓Markdown gives way to Distribution first Distribution read since July
2026-09-24Read Markdown6.18-23.3% to today ✓Markup gives way to Markdown after an 18% slide in 5 weeks
2026-08-22Read Markup7.57-37.4% to today Distribution gives way to Markup after a 30% rise in 7 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Avino Silver & Gold Mines Ltd. holds its Markdown at $4.74. The statistical read favours the sellers, held for 46 days.
As held on the ledger · 2026-11-04
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 46 days
Price at the screen
$4.74
Valuation
17.85 trailing · 9.27 forward price to earnings
Values screen
PASS· score 97.0
Beta
3.01
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.45%
Below 33%
Interest-bearing debt is just 0.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
7.59%
Below 33%
Cash held in interest-bearing accounts and securities is 7.6% of assets, under the one-third limit.
Pass
Receivables
0.00%
Below 49%
Money owed to the company is 0.0% of assets, under the 49% limit.
Pass
Revenue purity
1.53%
Below 5%
Only 1.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Avino Silver & Gold Mines clears all five screens. Its business is in a permissible area, its debt is near-nil, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when ASM's ethical verdict changes
Today ASM passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Fair value under review. Our model's value is 1.64x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Silver from Mexico looks cheap until prices turn
Picture a Mexican mine crew hauling silver and gold out of the ground while global metal prices lurch like a rollercoaster. Avino shows revenue doubling, a 33 percent profit margin and 18 percent return on equity, all at a forward multiple of just 6.8 times. The shares sit 35 percent below our fair value, the ethical screen clears without issue, and the moat is rated moderate.
Yet this is a classic cyclical trap. Low multiples in precious metals often mark peak earnings rather than bargains, and any drop in silver or gold prices can wipe out those margins fast. Currency swings, permitting delays and four sparse analyst notes add further uncertainty even with a median target at 12 dollars.
Commodity cycles reward patience and punish overconfidence. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
ASM trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-01Markdown$4.34-16.4%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 16.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-10-25Markdown$5.19+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-10-18Markdown$5.19-12.2%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 12.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-10-11Markdown · changed$5.91+0.0%Entry 9
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-10-02Distribution · changed$5.91-4.4%Entry 8
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-09-24Markdown · changed$6.18-18.4%Entry 7
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 18.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11. Since the last review it its composite score rose.
2026-08-22Markup · changed$7.57+37.6%Entry 6
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 37.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-07-21Distribution$5.50-5.8%Entry 5
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.8% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-07-18Distribution$5.84+0.0%Entry 4
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
2026-07-17Distribution$5.84+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (97). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 10% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 56%. Our forward projection puts the odds of a 10% gain over the next month near 47%. The street (4 analysts) rates it strong buy, with a mean price target of $11.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
